Host deficiency in ephrin-A1 inhibits breast cancer metastasis [version 1; peer review: 2 approved]
Background: The conventional dogma of treating cancer by focusing on the elimination of tumor cells has been recently refined to include consideration of the tumor microenvironment, which includes host stromal cells. Ephrin-A1, a cell surface protein involved in adhesion and migration, has been show...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2020-03-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/9-217/v1 |
id |
doaj-d77f234c236642d4b20c33c4c9dc8270 |
---|---|
record_format |
Article |
spelling |
doaj-d77f234c236642d4b20c33c4c9dc82702020-11-25T03:56:13ZengF1000 Research LtdF1000Research2046-14022020-03-01910.12688/f1000research.22689.125051Host deficiency in ephrin-A1 inhibits breast cancer metastasis [version 1; peer review: 2 approved]Eileen Shiuan0Ashwin Inala1Shan Wang2Wenqiang Song3Victoria Youngblood4Jin Chen5Dana M. Brantley-Sieders6Medical Scientist Training Program, Vanderbilt University, Nashville, TN, 37232, USAProgram in Cancer Biology, Vanderbilt University, Nashville, TN, 37232, USAVeterans Affairs Medical Center, Tennessee Valley Healthcare System, Nashville, TN, 37212, USAVeterans Affairs Medical Center, Tennessee Valley Healthcare System, Nashville, TN, 37212, USASchool of Nursing, Duke University, Durham, NC, 27710, USADivision of Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, TN, 37232, USADivision of Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, TN, 37232, USABackground: The conventional dogma of treating cancer by focusing on the elimination of tumor cells has been recently refined to include consideration of the tumor microenvironment, which includes host stromal cells. Ephrin-A1, a cell surface protein involved in adhesion and migration, has been shown to be tumor suppressive in the context of the cancer cell. However, its role in the host has not been fully investigated. Here, we examine how ephrin-A1 host deficiency affects cancer growth and metastasis in a murine model of breast cancer. Methods: 4T1 cells were orthotopically implanted into the mammary fat pads or injected into the tail veins of ephrin-A1 wild-type (Efna1+/+), heterozygous (Efna1+/-), or knockout (Efna1-/-) mice. Tumor growth, lung metastasis, and tumor recurrence after surgical resection were measured. Flow cytometry and immunohistochemistry (IHC) were used to analyze various cell populations in primary tumors and tumor-bearing lungs. Results: While primary tumor growth did not differ between Efna1+/+, Efna1+/-, and Efna1-/- mice, lung metastasis and primary tumor recurrence were significantly decreased in knockout mice. Efna1-/- mice had reduced lung colonization of 4T1 cells compared to Efna1+/+ littermate controls as early as 24 hours after tail vein injection. Furthermore, established lung lesions in Efna1-/- mice had reduced proliferation compared to those in Efna1+/+ controls. Conclusions: Our studies demonstrate that host deficiency of ephrin-A1 does not impact primary tumor growth but does affect metastasis by providing a less favorable metastatic niche for cancer cell colonization and growth. Elucidating the mechanisms by which host ephrin-A1 impacts cancer relapse and metastasis may shed new light on novel therapeutic strategies.https://f1000research.com/articles/9-217/v1 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Eileen Shiuan Ashwin Inala Shan Wang Wenqiang Song Victoria Youngblood Jin Chen Dana M. Brantley-Sieders |
spellingShingle |
Eileen Shiuan Ashwin Inala Shan Wang Wenqiang Song Victoria Youngblood Jin Chen Dana M. Brantley-Sieders Host deficiency in ephrin-A1 inhibits breast cancer metastasis [version 1; peer review: 2 approved] F1000Research |
author_facet |
Eileen Shiuan Ashwin Inala Shan Wang Wenqiang Song Victoria Youngblood Jin Chen Dana M. Brantley-Sieders |
author_sort |
Eileen Shiuan |
title |
Host deficiency in ephrin-A1 inhibits breast cancer metastasis [version 1; peer review: 2 approved] |
title_short |
Host deficiency in ephrin-A1 inhibits breast cancer metastasis [version 1; peer review: 2 approved] |
title_full |
Host deficiency in ephrin-A1 inhibits breast cancer metastasis [version 1; peer review: 2 approved] |
title_fullStr |
Host deficiency in ephrin-A1 inhibits breast cancer metastasis [version 1; peer review: 2 approved] |
title_full_unstemmed |
Host deficiency in ephrin-A1 inhibits breast cancer metastasis [version 1; peer review: 2 approved] |
title_sort |
host deficiency in ephrin-a1 inhibits breast cancer metastasis [version 1; peer review: 2 approved] |
publisher |
F1000 Research Ltd |
series |
F1000Research |
issn |
2046-1402 |
publishDate |
2020-03-01 |
description |
Background: The conventional dogma of treating cancer by focusing on the elimination of tumor cells has been recently refined to include consideration of the tumor microenvironment, which includes host stromal cells. Ephrin-A1, a cell surface protein involved in adhesion and migration, has been shown to be tumor suppressive in the context of the cancer cell. However, its role in the host has not been fully investigated. Here, we examine how ephrin-A1 host deficiency affects cancer growth and metastasis in a murine model of breast cancer. Methods: 4T1 cells were orthotopically implanted into the mammary fat pads or injected into the tail veins of ephrin-A1 wild-type (Efna1+/+), heterozygous (Efna1+/-), or knockout (Efna1-/-) mice. Tumor growth, lung metastasis, and tumor recurrence after surgical resection were measured. Flow cytometry and immunohistochemistry (IHC) were used to analyze various cell populations in primary tumors and tumor-bearing lungs. Results: While primary tumor growth did not differ between Efna1+/+, Efna1+/-, and Efna1-/- mice, lung metastasis and primary tumor recurrence were significantly decreased in knockout mice. Efna1-/- mice had reduced lung colonization of 4T1 cells compared to Efna1+/+ littermate controls as early as 24 hours after tail vein injection. Furthermore, established lung lesions in Efna1-/- mice had reduced proliferation compared to those in Efna1+/+ controls. Conclusions: Our studies demonstrate that host deficiency of ephrin-A1 does not impact primary tumor growth but does affect metastasis by providing a less favorable metastatic niche for cancer cell colonization and growth. Elucidating the mechanisms by which host ephrin-A1 impacts cancer relapse and metastasis may shed new light on novel therapeutic strategies. |
url |
https://f1000research.com/articles/9-217/v1 |
work_keys_str_mv |
AT eileenshiuan hostdeficiencyinephrina1inhibitsbreastcancermetastasisversion1peerreview2approved AT ashwininala hostdeficiencyinephrina1inhibitsbreastcancermetastasisversion1peerreview2approved AT shanwang hostdeficiencyinephrina1inhibitsbreastcancermetastasisversion1peerreview2approved AT wenqiangsong hostdeficiencyinephrina1inhibitsbreastcancermetastasisversion1peerreview2approved AT victoriayoungblood hostdeficiencyinephrina1inhibitsbreastcancermetastasisversion1peerreview2approved AT jinchen hostdeficiencyinephrina1inhibitsbreastcancermetastasisversion1peerreview2approved AT danambrantleysieders hostdeficiencyinephrina1inhibitsbreastcancermetastasisversion1peerreview2approved |
_version_ |
1724466325132148736 |